Overcoming barriers by local drug delivery with liposomes

被引:201
|
作者
Antimisiaris, S. G. [1 ,2 ]
Marazioti, A. [1 ]
Kannavou, M. [1 ,2 ]
Natsaridis, E. [1 ,2 ]
Gkartziou, F. [2 ]
Kogkos, G. [1 ,2 ]
Mourtas, S. [1 ]
机构
[1] Univ Patras, Sch Hlth Sci, Dept Pharm, Lab Pharmaceut Technol, Rion 26504, Greece
[2] Fdn Res & Technol Hellas FORTH ICES, Inst Chem Engn Sci, Rion 26504, Greece
关键词
Liposomes; Drug; Topical routes; Local delivery; Administration; Ocular; Pulmonary; Nasal; Oral; Intratumoral; Vaginal; Vaccine; COVID-19; BLOOD-BRAIN-BARRIER; SURFACE-MODIFIED LIPOSOMES; IN-VITRO CHARACTERIZATION; SUSTAINED-RELEASE; TRANSDERMAL DELIVERY; CATIONIC LIPOSOMES; LOADED LIPOSOMES; OCULAR DELIVERY; DRY POWDER; BIOLOGICAL BARRIERS;
D O I
10.1016/j.addr.2021.01.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Localized or topical administration of drugs may be considered as a potential approach for overcoming the problems caused by the various biological barriers encountered in drug delivery. The combination of using localized administration routes and delivering drugs in nanoparticulate formulations, such as liposomes, may have additional advantages. Such advantages include prolonged retention of high drug loads at the site of action and controlled release of the drug, ensuring prolonged therapeutic effect; decreased potential for side-effects and toxicity (due to the high topical concentrations of drugs); and increased protection of drugs from possible harsh environments at the site of action. The use of targeted liposomal formulations may further potentiate any acquired therapeutic advantages. In this review we present the most advanced cases of localized delivery of liposomal formulations of drugs, which have been investigated pre-clinically and clinically in the last ten years, together with the reported therapeutic advantages, in each case. (c) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页码:53 / 86
页数:34
相关论文
共 50 条
  • [21] Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance
    Peng, Chuanqi
    Huang, Yingyu
    Zheng, Jie
    JOURNAL OF CONTROLLED RELEASE, 2020, 322 : 64 - 80
  • [22] Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
    Baryakova, Tsvetelina H.
    Pogostin, Brett H.
    Langer, Robert
    McHugh, Kevin J.
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (05) : 387 - 409
  • [23] Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
    Tsvetelina H. Baryakova
    Brett H. Pogostin
    Robert Langer
    Kevin J. McHugh
    Nature Reviews Drug Discovery, 2023, 22 : 387 - 409
  • [24] Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
    Raut, Sangram
    Mooberry, Linda
    Sabnis, Nirupama
    Garud, Ashwini
    Dossou, Akpedje Serena
    Lacko, Andras
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [25] Overcoming delivery barriers in immunotherapy for glioblastoma
    Rui, Yuan
    Green, Jordan J.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021, 11 (06) : 2302 - 2316
  • [26] Overcoming barriers to nonviral gene delivery
    Behr, JP
    TARGETING OF DRUGS: STRATEGIES FOR GENE CONSTRUCTS AND DELIVERY, 2000, 323 : 76 - 80
  • [27] Overcoming delivery barriers in immunotherapy for glioblastoma
    Yuan Rui
    Jordan J. Green
    Drug Delivery and Translational Research, 2021, 11 : 2302 - 2316
  • [28] SPECIAL DELIVERY - OVERCOMING THE BARRIERS TO ADOPTION
    ALLEN, CL
    POLICY REVIEW, 1989, 49 : 46 - 53
  • [29] Principles of rational design of thermally targeted liposomes for local drug delivery
    Tejera-Garcia, Roberto
    Parkkila, Petteri
    Zamotin, Vladimir
    Kinnunen, Paavo K. J.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2014, 10 (06) : 1243 - 1252
  • [30] Mucoadhesive alginate pastes with embedded liposomes for local oral drug delivery
    Shtenberg, Yarden
    Goldfeder, Mor
    Prinz, Hodaya
    Shainsky, Janna
    Ghantous, Yasmine
    Abu El-Naaj, Imad
    Schroeder, Avi
    Bianco-Peled, Havazelet
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 111 : 62 - 69